Joseph Devaughn Williams, LCSW | |
1111 Amsterdam Avenue, New York, 10025 10025 | |
(718) 810-8021 | |
(347) 548-4554 |
Full Name | Joseph Devaughn Williams |
---|---|
Gender | Male |
Speciality | Social Worker - Clinical |
Location | 1111 Amsterdam Avenue, New York, 10025 |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1598356685 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 090721 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Joseph Devaughn Williams, LCSW 16911 144th Ave, Jamaica, NY 11434 Ph: (718) 810-8021 | Joseph Devaughn Williams, LCSW 1111 Amsterdam Avenue, New York, 10025 10025 Ph: (718) 810-8021 |
News Archive
Saving lives is truly the mission of HealthFREE.org, a South Florida non-profit organization currently working to provide help, hope and healing to those affected by the devastation of the recent hurricanes. In efforts to effectively serve the residents of Puerto Rico, leadership from HealthFREE.org met with Coalition of Hope to discuss how both organizations can collaborate to save lives of fellow Americans on the island.
Coronary heart disease is associated with a worse performance in mental processes such as reasoning, vocabulary and verbal fluency, according to a study of 5837 middle-aged Whitehall civil servants. The study also found that the longer ago the heart disease had been diagnosed, the worse was the person's cognitive performance and this effect was particularly marked in men.
Advanced Data Systems (ADS) has been designated an eHealthConnecticut REC Qualified Vendor. Qualified EHR Vendor status assures medical practices in CT that ADS and the MedicsDocAssistant EHR have met the REC's standards and criteria for inclusion in the eHealthConnecticut REC.
Xencor, Inc., an antibody discovery and development company, announced today that it has entered into an antibody optimization collaboration with CSL, Ltd. The collaboration will provide CSL with access to Xencor's XmAb technology platform to enhance the ADCC effector function of its therapeutic antibodies.
› Verified 1 days ago